MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform
Guest UserSeptember 27, 2019
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

Guest UserSeptember 30, 2019
Next

F-star appoints Dr Louis Kayitalire as Chief Medical Officer

Guest UserJune 10, 2019

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact